SIMULATION STUDY OF PRECLINICAL DEVELOPMENT OF ANTICANCER DRUGS

被引：0
|
作者：
GORDON, MH [1 ]
机构：
[1] NCI,DIV CANC TREATMENT,BETHESDA,MD 20014
来源：
CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT | 1974年 / 5卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：65 / 78
页数：14
相关论文
共 50 条
  • [1] Regulatory considerations for preclinical development of anticancer drugs
    DeGeorge J.J.
    Ahn C.-H.
    Andrews P.A.
    Brower M.E.
    Giorgio D.W.
    Goheer M.A.
    Lee-Ham D.Y.
    McGuinn W.D.
    Schmidt W.
    Sun C.J.
    Tripathi S.C.
    Cancer Chemotherapy and Pharmacology, 1997, 41 (3) : 173 - 185
  • [2] Regulatory considerations for preclinical development of anticancer drugs
    DeGeorge, JJ
    Ahn, CH
    Andrews, PA
    Brower, ME
    Giorgio, DW
    Goheer, MA
    Lee-Ham, DY
    McGuinn, WD
    Schmidt, W
    Sun, CJ
    Tripathi, SC
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 41 (03) : 173 - 185
  • [3] Preclinical evaluation of anticancer drugs
    Lavelle, F
    BULLETIN DU CANCER, 1998, 85 (10) : 837 - 842
  • [4] SPARSOMYCIN AND ITS ANALOGS - A PRECLINICAL STUDY ON NOVEL ANTICANCER DRUGS
    ZYLICZ, Z
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1989, 11 (02) : 64 - 65
  • [5] Anticancer Metallotherapeutics in Preclinical Development
    Kaluderovic, G. N.
    Paschke, R.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (31) : 4738 - 4752
  • [6] Methodogy for preclinical research on new anticancer drugs
    Debussche, L
    BULLETIN DU CANCER, 2001, 88 (01) : 67 - 74
  • [7] Progress in preclinical and clinical studies for the development of new anticancer drugs in Japan, with emphasis on taxanes
    Saijo, N
    Nishio, K
    Ohta, S
    Arioka, H
    Funayama, Y
    Fukuoka, K
    Kurokawa, H
    Nomoto, T
    Ishida, T
    Yamamoto, N
    Tamura, T
    Shinkai, T
    Eguchi, K
    Ohe, Y
    Kunito, H
    Ohtsu, T
    Sasaki, Y
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 38 : S11 - S15
  • [8] THE DEVELOPMENT OF ANTICANCER DRUGS
    JARMAN, M
    CHEMISTRY IN BRITAIN, 1989, 25 (01) : 51 - 54
  • [9] Cannabinoids as anticancer drugs: current status of preclinical research
    Hinz, Burkhard
    Ramer, Robert
    BRITISH JOURNAL OF CANCER, 2022, 127 (01) : 1 - 13
  • [10] Cannabinoids as anticancer drugs: current status of preclinical research
    Burkhard Hinz
    Robert Ramer
    British Journal of Cancer, 2022, 127 : 1 - 13
12345